See today's BioWorld
To read the full story, subscribe or sign in.

Long Wait for Data, Galena Buys Drug to Go Commercial

March 25, 2013
By Brian Orelli
Galena Biopharma Inc. has a bit of a wait ahead of it. The biotech initiated a Phase III trial testing NeuVax (nelipepimut-S) as an adjuvant breast cancer treatment at the beginning of 2012.
BioWorld